MacroGenics
MGNX
#8711
Rank
โ‚น24.81 B
Marketcap
โ‚น389.52
Share price
0.50%
Change (1 day)
184.11%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2026 (TTM): -โ‚น134.65

According to MacroGenics's latest financial reports the company's current EPS (TTM) is -โ‚น146.79. In 2025 the company made an earnings per share (EPS) of -โ‚น113.21 a decrease over its 2024 EPS that were of -โ‚น102.66.

EPS history for MacroGenics from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น134.6518.93%
2025-โ‚น113.2110.28%
2024-โ‚น102.66613.33%
2023-โ‚น14.39-92.31%
2022-โ‚น187.08-42.14%
2021-โ‚น323.3236.44%
2020-โ‚น236.97-21.84%
2019-โ‚น303.17-24.58%
2018-โ‚น401.99675.93%
2017-โ‚น51.81-68.05%
2016-โ‚น162.14168.25%
2015-โ‚น60.44-55%
2014-โ‚น134.323400%
2013-โ‚น3.84-108.68%
2012โ‚น44.2224.49%
2011โ‚น35.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น125.68-185.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,708-1,944.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,389-1,046.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น711.87-584.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น342.97-333.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น341.55-332.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-โ‚น219.70 49.67%๐Ÿ‡บ๐Ÿ‡ธ USA